BioSpace News Archive

Business

Camel-IDS Grabs $42 Million in Funding to Support Treatment for Brain Lesions

In announcing the round, Camel-IDS said the finances will be used for a phase Ib/II trial of its lead program CAM-H2, a treatment option in HER2-positive cancers, while further developing preclinical programs and broadening the pipeline.

November 16, 2018
·
2 min read
·
Alex Keown
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children with poor aerobic fitness

Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.

November 16, 2018
·
2 min read
Business

BerGenBio ASA: Invitation to Third Quarter 2018 Results Presentation and Webcast

BerGenBio ASA will announce its results for the third quarter 2018 on Tuesday, 13 November 2018.

November 16, 2018
·
1 min read
Policy

Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca

First-in-class enterprise workflow platform for streamlining cell line development operations

November 16, 2018
·
4 min read
Job Trends

Apple’s Face ID Security Available in Mobile App for Clinical Trial Management

Crucial Data Solutions announces the latest update to their native mobile app for clinical trial data collection and management. TrialKit™, an eClinical platform, has incorporated Apple’s biometric technologies for user authentication.

November 16, 2018
·
3 min read
Biotech Beach

Mesa Biotech to Demonstrate New Accula Molecular POC Testing Platform at Medica 2018

Company to Participate in USA Corporate Executive Office Program

November 16, 2018
·
2 min read
BioCapital

Risk for Cancer Goes to the Next Level with Every Five Point Increase in BMI

A new Report from the American Institute for Cancer Research (AICR) sounds the alarm about what is driving the obesity-cancer crisis. There is strong scientific evidence that having overweight and obesity cause at least 12 types of cancer.

November 16, 2018
·
3 min read
BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

Winner SunRegen Healthcare is focused on innovative treatments for patients with neurodegenerative eye diseases

November 16, 2018
·
5 min read
Biotech Beach

MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices

Real-world study shows that SelectMDx helps urologists more confidently determine the need for an initial prostate biopsy

November 16, 2018
·
6 min read
Policy

Ability Pharmaceuticals Announces FDA-Orphan Drug Designation for ABTL0812 in Biliary Tract Cancer

Ability Pharmaceuticals announced today that it has received orphan-drug designation (ODD) for ABTL0812 from the US Food and Drug administration (FDA) for the treatment of biliary tract cancer.

November 16, 2018
·
4 min read